Nasdaq · Industrials
HEALTHEQUITY, INC. (HQY)
As-reported financials and recent SEC filings for HEALTHEQUITY, INC., latest fiscal period FY2026. Every figure is pulled straight from the company’s EDGAR filings — no estimates.
Snapshot
Revenue
$1.31B
Net income
$215.2M
Net margin
16.4%
Diluted EPS
$2.46
ROE
10.2%
P/E (TTM)
33.1×
Market cap
$7.40B
Debt / equity
0.5×
Income statement (as reported)
| Line | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| Revenue | $1.31B | $1.20B | $999.6M | $861.7M | $756.6M |
| Gross profit | $913.1M | $777.3M | $622.6M | $491.9M | $424.8M |
| Operating income | $322.5M | $162.3M | $117.7M | $9.1M | $-24.2M |
| Net income | $215.2M | $96.7M | $55.7M | $-26.1M | $-44.3M |
| Diluted EPS | $2.46 | $1.09 | $0.64 | $-0.31 | $-0.53 |
Source: company XBRL financial statements on SEC EDGAR.
Recent SEC filings
S-82026-06-26
View on EDGAR →8-K2026-06-26
View on EDGAR →42026-06-02
View on EDGAR →42026-06-01
View on EDGAR →42026-06-01
View on EDGAR →1442026-05-29
View on EDGAR →1442026-05-28
View on EDGAR →1442026-05-28
View on EDGAR →Go deeper on HQY
Search HEALTHEQUITY, INC.’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.
Start freeData sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.